Pentoxifylline added to ulcerative colitis treatment
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether adding the medicine pentoxifylline to standard care can help people with ulcerative colitis. It’s designed to see if this combination improves symptoms by changing inflammation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be at least 18 years old
- You must not be currently pregnant, and you need to use effective birth control (or not be able to become pregnant)
- You cannot be breastfeeding
- You must not have serious liver or kidney problems
- You must not have colorectal cancer or have very severe ulcerative colitis
- You cannot be using steroid medicines (either as pills by mouth, or rectal/steroid enemas) or other immune-suppressing/biologic medicines
- You should not currently have alcohol and/or drug addiction
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if the drug pentoxifylline can help people with mild to moderate ulcerative colitis. It may offer a new treatment option for those not on other strong medications.
This Phase 2 study tests whether adding metformin to usual care can help people with mild to moderate ulcerative colitis. The goal is to see if it improves symptoms and disease control compared with standard therapy alone.
This trial tests a new medicine (TQH3906) for people with moderate to severe ulcerative colitis or Crohn's disease that hasn't improved with other treatments. The goal is to see if it can help control inflammation in the gut.
This study tests if pentoxifylline, a medicine typically used for circulation, can help reduce joint inflammation in people with rheumatoid arthritis who still have active symptoms despite taking standard DMARDs.
This trial tests whether adding a probiotic supplement and trace elements to your current treatment helps manage mild to moderate ulcerative colitis. It aims to see if these additions can improve symptoms and quality of life.
This trial tests whether adding pentoxifylline (a medication that improves blood flow) to your current psoriasis cream treatment helps reduce psoriasis patches. You'll be on stable topical therapy for at least 2 weeks, then the study will see if the added medication improves your skin.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.